知柏地黄丸辅助治疗糖尿病肾病临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.2

基金项目:


Clinical Study on Zhibai Dihuang Pills in Adjuvant Treatment of Diabetic Nephropathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察知柏地黄丸辅助治疗糖尿病肾病的临床疗效。方法:选择糖尿病肾病患者196 例,按照随机数字表法分为对照组与观察组各98 例。2 组均采用常规西药治疗,对照组给予卡托普利+盐酸二甲双胍片治疗,观察组在对照组的基础上加用知柏地黄丸治疗。观察2 组临床疗效及治疗期间的不良反应情况,检测2 组治疗前后血糖指标[空腹血糖(FBG)、餐后2h 血糖(P2hBG)、糖化血红蛋白(HbA1c)]、血脂指标[甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白-胆固醇(LDL-C)、高密度脂蛋白-胆固醇(HDL-C)]、肾功能指标[血清肌酐(SCr)、尿素氮(BUN)] 水平变化。结果:总有效率观察组为94.90%,对照组为81.63%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组血糖指标FBG、P2hBG、HbA1c 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组FBG、P2hBG、HbA1c 水平均较治疗前降低(P<0.05),且观察组FBG、P2hBG、HbA1c 水平均低于对照组(P<0.05)。治疗前,2 组血脂指标TG、TC、LDL-C、HDL-C 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组TG、TC、LDL-C 水平较治疗前降低,HDL-C 水平较治疗前升高(P<0.05);且观察组上述各项指标改善均较对照组更显著(P<0.05)。治疗前,2 组肾功能指标SCr、BUN 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组SCr、BUN 水平均较治疗前降低(P<0.05),且观察组SCr、BUN 水平均低于对照组(P<0.05)。治疗期间,观察组不良反应发生率为20.41%,对照组为18.37%,2 组比较,差异无统计学意义(P>0.05)。结论:在常规西药的基础上给予知柏地黄丸治疗糖尿病肾病,有助于短期内改善血糖、血脂及肾功能水平,提高临床疗效,且无明显增加不良反应。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Zhibai Dihuang pills in the adjuvant treatment of diabetic nephropathy. Methods:A total of 196 cases of patients with diabetic nephropathy were selected and divided into the control group and the observation group according to the random number table method, with 98 cases in each group. Both groups were treated with routine western medicine; the control group was treated with captopril and metformin hydrochloride tablets, and the observation group was additionally treated with Zhibai Dihuang pills based on the treatment of the control group. The adverse reactions during treatment and the clinical effects in the two groups were observed. The changes in levels of blood glucose indexes including fasting blood glucose(FBG),two-hour postprandial blood glucose(P2hBG) and glycosylated hemoglobin(HbA1c),blood lipid indexes including triglyceride(TG),total cholesterol(TC), low- density lipoprotein- cholesterol(LDL- C) and high- density lipoprotein- cholesterol(HDL- C) as well as kidney function indexes including serum creatinine(SCr) and urea nitrogen(BUN) before and after treatment in the two groups were detected. Results: The total effective rate was 94.90% in the observation group and 81.63% in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of blood glucose indexes including FBG, P2hBG and HbA1c between the two groups(P>0.05). After treatment, the levels of FBG, P2hBG and HbA1c in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of FBG,P2hBG and HbA1c in the observation group were lower than those in the control group(P< 0.05). Before treatment,there was no significant difference being found in the comparison of the levels of TG,TC,LDL-C and HDL-C between the two groups(P>0.05). After treatment,the levels of TG,TC and LDL-C in the two groups were decreased when compared with those before treatment,and the levels of HDL- C were increased(P<0.05). The improvement of the above indexes in the observation group was more significant than that in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of kidney function indexes including SCr and BUN between the two groups(P>0.05). After treatment, the levels of SCr and BUN in the two groups were decreased when compared with those before treatment(P<0.05), and the levels of SCr and BUN in the observation group were lower than those in the control group(P<0.05). During treatment,the incidence of adverse reactions was 20.41% in the observation group and 18.37% in the control group,there being no significant difference between the two groups(P>0.05). Conclusion:Based on routine western medicine, the application of Zhibai Dihuang pills for diabetic nephropathy can help to improve the levels of blood glucose and blood lipid and kidney function in a short term,as well as enhance the clinical effect,without a significant increase in adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

施爱梅.知柏地黄丸辅助治疗糖尿病肾病临床研究[J].新中医,2022,54(18):6-10

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-28
  • 出版日期: